Telix News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Telix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Telix Today - Breaking & Trending Today

Telix Pharmaceuticals Limited: Telix Opens European Radiopharmaceutical Production Facility

Telix has unveiled its new, state-of-art radiopharmaceutical facility in Brussels South as part of its first stage investment of €14.1 million ($A21.2 million) Located in Walloon's 'Radiopharma ....

Waals Gewest , Mecklenburg Vorpommern , United States , United Kingdom , Walloon Region , Bruxelles Capitale , Kyahn Williamson , Christian Behrenbruch , Raphael Ortiz , Willy Borsus , Stefan Klotter , Australian Securities Exchange , Drug Administration , Medrays Intell Nuclear Medicine , Telix Manufacturing Solutions , European Union , Prnewswire Telix Pharmaceuticals Limited , Research Centre , Corporate Communications , European Commission , Australian Therapeutic Goods Administration , Telix Pharmaceuticals , Health Canada , Wallonia Export Investment Agency , Download The Telix Manufacturing Solutions , Brussels South ,

Telix Pharmaceuticals Limited: Telix to Supply Bayer with Illuccix® for Global Phase III Prostate Cancer Study

MELBOURNE, Australia, May 7, 2023 /PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an agreement with Bayer AG (Bayer) to ....

United States , United Kingdom , Bayer Cross , Kyahn Williamson , Colin Hayward , Australian Securities Exchange , Bayer Ag , Australian Therapeutic Goods Administration , Corporate Communications , Telix Pharmaceuticals , European Union , Health Canada , Prnewswire Telix Pharmaceuticals Limited , Drug Administration , Orion Corporation , Pharmaceuticals Limited , Chief Medical Officer , Telix Pharmaceuticals Limited ,

Telix Pharmaceuticals Limited: ZIRCON Phase III Kidney Cancer Imaging Study Presented at AUA: New Data Confirms Efficacy in Masses 2cm or Smaller

MELBOURNE, Australia, May 1, 2023 /PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces additional positive results from its completed pivotal Phase III ....

United States , United Kingdom , Los Angeles , Colin Hayward , Brian Shuch , Kyahn Williamson , Drug Administration , American Urological Association , Telix Pharmaceuticals , Australian Therapeutic Goods Administration , Institute Of Urologic Oncology Los Angeles , Australian Securities Exchange , Corporate Communications , Telix Pharmaceuticals Limited Disclosure Committee , European Union , Health Canada , Kidney Cancer Program , Prnewswire Telix Pharmaceuticals Limited , Pharmaceuticals Limited , Associate Professor Brian Shuch , Urologic Oncology , Annual Meeting , Chief Medical Officer , Professor Brian Shuch , Telix Pharmaceuticals Limited ,

Telix Pharmaceuticals Limited: Telix Accelerates Artificial Intelligence (AI) Development Program with Acquisition of Dedicaid

MELBOURNE, Australia, April 26, 2023 /PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the expansion of its artificial intelligence (AI) capability ....

United Kingdom , United States , Thomas Beyer , Mark Europe , Dedicaid Gmbh , Michael Wheatcroft , University Vienna , Health Canada , Drug Administration , Australian Therapeutic Goods Administration , Telix Pharmaceuticals , Australian Securities Exchange , Head Of The Research Domain Quantitative Imaging , Telix Pharmaceuticals Limited Disclosure Committee , Prnewswire Telix Pharmaceuticals Limited , Pharmaceuticals Limited , Vienna Based Dedicaid Gmbh , Medical University , Medical University Vienna , United States Food , Chief Scientist , Research Domain , Quantitative Imaging , Medical Physics , Listing Rule , Telix Pharmaceuticals Limited ,

Telix Pharmaceuticals Limited: Olaratumab Antibody Licensed from Lilly Demonstrates Proof of Concept as a Theranostic Radiopharmaceutical

MELBOURNE, Australia, April 16, 2023 /PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces successful preclinical development of radiolabelled olaratumab ....

United States , United Kingdom , Kyahn Williamson , Eli Lilly , Michael Wheatcroft , Alpha Pdgfra , Corporate Communications , American Cancer Society , Telix Pharmaceuticals Limited Disclosure Committee , Company Lilly , Australian Securities Exchange , Telix Pharmaceuticals , Australian Therapeutic Goods Administration , Prnewswire Telix Pharmaceuticals Limited , Drug Administration , Health Canada , Pharmaceuticals Limited , Platelet Derived Growth Factor Receptor Alpha , Soft Tissue Sarcoma , Positron Emission Tomography , Chief Scientist , Telix Pharmaceuticals Limited , Cancer Society , Adv Med ,